Biblio

135 resultats trouvés
Filtres: Auteur is Wendling, D.  [Clear All Filters]
L
Guillot X., Tordi N., Laheurte C., Pazart L., Prati C., Saas P., Wendling D..  2016.  LOCAL CRYOTHERAPY (PULSED CO2 OR ICE) DECREASES IL-6, IL-1 beta AND VEGF SYNOVIAL LEVELS IN KNEE ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. 75:896.
Guillot X., Tordi N., Laheurte C., Pazart L., Prati C., Saas P., Wendling D..  2018.  LOCAL ICE CRYOTHERAPY DECREASES PROSTAGLANDIN-E2, NF-KB AND IL-6 SYNOVIAL LEVELS IN ARTHRITIC KNEES COMPARED TO CONTRALATERAL NON-TREATED JOINTS. ANNALS OF THE RHEUMATIC DISEASES. 77:1239.
Guillot X., Tordi N., Laheurte C., Pazart L., Prati C., Saas P., Wendling D..  2019.  Local ice cryotherapy decreases synovial interleukin 6, interleukin 1 beta, vascular endothelial growth factor, prostaglandin-E2, and nuclear factor kappa B p65 in human knee arthritis: a controlled study. ARTHRITIS RESEARCH & THERAPY. 21:180.
M
Richebe P., Godot S., Coiffier G., Guggenbuhl P., Mulleman D., Couderc M., Dernis E., Deprez V., Salliot C., Urien S. et al..  2020.  MANAGEMENT AND OUTCOME OF SEPTIC ARTHRITIS OF NATIVE JOINT: A NATIONWIDE SURVEY. ANNALS OF THE RHEUMATIC DISEASES. 79:817-818.
Mekhail C., Guillot X., Prati C., Saas P., Mourey G., Wendling D..  2018.  MEASUREMENT OF THE PRO-COAGULANT ACTIVITY OF MICROPARTICLES IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: PROSPECTIVE STUDY. ANNALS OF THE RHEUMATIC DISEASES. 77:1227.
Verhoeven F., Prati C., Chouk M., Demougeot C., Wendling D..  2021.  METHOTREXATE AND CARDIOVASCULAR RISK IN RHEUMATIC DISEASES:A COMPREHENSIVE REVIEW. ANNALS OF THE RHEUMATIC DISEASES. 80:1159-1160.
Bordy R., Verhoeven E., Tournier-Nappey M., Wendling D., Demougeot C., Totoson P..  2019.  Methotrexate did not improve endothelial function in rheumatoid arthritis: a study in rats with adjuvant-induced arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 37:81-88.
Bordy R., Verhoeven E., Tournier-Nappey M., Wendling D., Demougeot C., Totoson P..  2019.  Methotrexate did not improve endothelial function in rheumatoid arthritis: a study in rats with adjuvant-induced arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 37:81-88.
Totoson P., Wendling D., Prati C., Demougeot C..  2018.  MODULATION OF ENDOTHELIAL FUNCTION BY PROINFLAMMATORY CYTOKINES INVOLVED IN RHEUMATOID ARTHRITIS. FOCUS ON IL-17A, IL-20, IL-23 AND IL-9. ANNALS OF THE RHEUMATIC DISEASES. 77:1251.
Benier V., Woronoff A.S, Verhoeven F., Chouk M., Wendling D., Prati C..  2021.  MONOCENTRIC RETROSPECTIVE DESCRIPTIVE STUDY OF A HOSPITAL POPULATION OF SPONDYLOARTHRITIS (SPA) WITH A HISTORY OF CANCER. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 39:1185.
Roux C.H, Foltz V., Maheu E., Baron G., Gandjbakhch F., Lukas C., Wendling D., Loeuille D., Lafforgue P., Euller-Ziegler L. et al..  2016.  MRI and serum biomarkers correlate with radiographic features in painful hand osteoarthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 34:991-998.
Roux C.H, Foltz V., Maheu E., Baron G., Gandjbakhch F., Lukas C., Wendling D., Loeuille D., Lafforgue P., Euller-Ziegler L. et al..  2016.  MRI and serum biomarkers correlate with radiographic features in painful hand osteoarthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 34:991-998.
N
Fianyo E., Wendling D., Poulain C., Farrenq V., Claudepierre P..  2014.  Non-radiographic axial spondyloarthritis: what is it? CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 32:1-4.
Fianyo E., Wendling D., Poulain C., Farrenq V., Claudepierre P..  2014.  Non-radiographic axial spondyloarthritis: what is it? CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 32:1-4.
Verhoeven F., Prati C., Maguin-Gate K., Totoson P., Wendling D., Demougeot C..  2016.  NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND ENDOTHELIAL FUNCTION IN RA: HARMFUL OR BENEFICIAL? A STUDY IN RAT ADJUVANT-INDUCED ARTHRITIS ANNALS OF THE RHEUMATIC DISEASES. 75:927.
Verhoeven F., Prati C., Totoson P., Bordy R., Wendling D., Demougeot C..  2017.  NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ARE MORE BENEFICIAL THAN ANTI-TNF alpha DRUGS ON THE RADIOGRAPHIC DAMAGE IN ARTHRITIS: A STUDY IN ADJUVANT INDUCED ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. 76:495-496.
O
Rabier M.BValnet, Hecquet S., Lepelley M., Verhoeven F., Prati C., Davani S., Wendling D..  2019.  Ocular troubles and JAK inhibitors: analysis of notifications from European pharmacovigilance database. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 33:22.
Rabier M.BValnet, Hecquet S., Lepelley M., Verhoeven F., Prati C., Davani S., Wendling D..  2019.  Ocular troubles and JAK inhibitors: analysis of notifications from European pharmacovigilance database. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 33:22.
P
Delattre E., Guillot X., Prati C., Wendling D..  2014.  PAMIDRONATE TREATMENT OF SAPHO SYNDROME: A RETROSPECTIVE STUDY OF 22 CASES. ANNALS OF THE RHEUMATIC DISEASES. 73:311.
Sparsa L., Afif N., Bularca S., Fricker A., Thiebault S., Dahan E., Wendling D., Sibilia J., Ardizzone M..  2014.  Paradoxical cutaneous reactions associated with tocilizumab therapy. REVUE DE MEDECINE INTERNE. 35:613-616.
Grange L., Carton L., Dachicourt J.N, Diebold R., Faugere M., Froukhi A., Laloyaux F., Schmidt G., Zaoui S., Wendling D..  2015.  PATIENT'S VERSION OF THE RECOMMENDATIONS OF THE FRENCH SOCIETY OF RHEUMATOLOGY (SFR) FOR SUPPORT IN CURRENT PRACTICE OF PATIENTS WITH SPONDYLOARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. 74:1148.
Verhoeven F., Tordi N., Prati C., Demougeot C., Mougin F., Wendling D..  2015.  PHYSICAL ACTIVITY AND RHEUMATOID ARTHRITIS, A SYSTEMATIC REVIEW. ANNALS OF THE RHEUMATIC DISEASES. 74:416.
Chouk M., Bordy R., Moretto U., Tournier-Nappey M., Prati C., Wendling D., Totoson P., Demougeot C..  2018.  PRISTANE-INDUCED ARTHRITIS IN DARK AGOUTI RAT: A NEW ANIMAL MODEL TO STUDY CARDIOVASCULAR DYSFUNCTION IN RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. 77:913.
Masson M., Kostine M., Barnetche T., Saraux A., Ruyssen-Witrand A., Thomas T., Wendling D., Truchetet M.E, Richez C., Schaeverbeke T..  2021.  PROTON PUMP INHIBITORS MAY IMPAIR RESPONSE TO TNF-INHIBITORS IN SPONDYLOARTHRITIS PATIENTS. ANNALS OF THE RHEUMATIC DISEASES. 80:1261-1262.
R
Pers Y.-M, Godfrin-Valnet M., Lambert J., Fortunet C., Constant E., Mura T., Pallot-Prades B., Jorgensen C., Maillefert J.-F, Marotte H. et al..  2014.  RESPONSE TO TOCILIZUMAB IN RHEUMATOID ARTHRITIS IS NOT INFLUENCED BY THE BODY MASS INDEX OF THE PATIENT. ANNALS OF THE RHEUMATIC DISEASES. 73:958.

Pages